Berberine: what the evidence actually shows

evidence catching-up  berberine — 'nature's Ozempic' hype, but the glucose evidence is real and growing

Reviewed by Substrate editorial, Independent research collective ·

⚠ Safety in context

Evidence by outcome

blood sugargrade Bmoderate certaintylowers fasting glucose and HbA1c; GI side effects common
heart healthgrade Bmoderate certaintyMeta-analysis of RCTs: berberine improved several cardiovascular risk factors — lowering total and LDL cholesterol, triglycerides, and blood pressure — versus control. It is a risk-factor signal, not a demonstrated reduction in cardiovascular events.
inflammationgrade Bmoderate certaintyMeta-analysis of 5 RCTs: berberine supplementation significantly decreased serum C-reactive protein versus control, with no significant heterogeneity between studies. The authors note patients with cardiovascular disease and diabetes may be the groups most likely to benefit; larger confirmatory trials are still needed.

People say · Evidence shows

Berberine is nature's Ozempic

aheadlargemarketing claim

Grade history

Re-review cadence: every 12 months (Grade A/B) · next scheduled by · methodology v1.

By outcome — the money pages

Compare

More

sources: PMID:38016844 · PMID:34956436 · PMID:36313096 · PMID:31519292

Cite this page

Reuse under CC-BY 4.0 with attribution to evidencebased.info.

Plain-text citation
Substrate. Berberine: what the evidence actually shows. https://evidencebased.info/interventions/berberine. Updated 2026-07-16.
BibTeX
@misc{substrate_terventionsberberine,
  author = {Substrate editorial},
  title  = {Berberine: what the evidence actually shows},
  year   = {2026},
  url    = {https://evidencebased.info/interventions/berberine},
  note   = {evidencebased.info}
}